Product Information
HYDROXYZINE PAM 25 MG CAP is a generic product labeled by Chartwell RX LLC, priced at $0.0642 per EA under NDC 62135081612. Its NADAC has been published 94 times since Sep 11, 2024.
Strength
25 mg/1
Manufacturer
Chartwell RX LLCNDC
62135081612
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
HYDROXYZINE PAMOATEApproval Type
Generic (ANDA)
FDA Application
ANDA201507On Market Since
6/3/2013
Pharmacological Classes
Price Statistics
The NADAC for HYDROXYZINE PAM 25 MG CAP has been published 94 times since Sep 11, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0642 per EA |
|---|---|
| All-time high | $0.0655 (Jun 10, 2026) |
| All-time low | $0.0541 (Nov 20, 2024) |
| 52-week high | $0.0655 |
| 52-week low | $0.0630 |
| Median price | $0.0640 |
| Average price | $0.0633 |
| Largest weekly change | -15.9% (Nov 20, 2024) |
| Weeks tracked | 94 |
| Tracking since | Sep 11, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Hydroxyzine pamoate market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of HYDROXYZINE PAM 25 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for HYDROXYZINE PAM 25 MG CAP, manufactured by Chartwell RX LLC, is $0.0642 per EA (NDC 62135081612), effective Jun 24, 2026.
How has the price of HYDROXYZINE PAM 25 MG CAP changed over time?
Over the history we have for it, the NADAC for HYDROXYZINE PAM 25 MG CAP has held within roughly two percent of its current level. It has been tracked across 94 weekly CMS publications since Sep 11, 2024.
What are the highest and lowest recorded NADAC prices for HYDROXYZINE PAM 25 MG CAP?
Since Sep 11, 2024, the NADAC for HYDROXYZINE PAM 25 MG CAP has ranged from a low of $0.0541 (Nov 20, 2024) to a high of $0.0655 (Jun 10, 2026), with a median of $0.0640 per EA.
Are there cheaper alternatives to HYDROXYZINE PAM 25 MG CAP?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of HYDROXYZINE PAM 25 MG CAP, so no direct lower-cost alternative is listed.
Who manufactures HYDROXYZINE PAM 25 MG CAP?
HYDROXYZINE PAM 25 MG CAP (NDC 62135081612) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification